About: Dabigatran Level Before Reversal Can Predict Hemostatic Effectiveness of Idarucizumab in a Real-World Setting   Goto Sponge  NotDistinct  Permalink

An Entity of Type : owl:Thing, within Data Space : data.idref.fr associated with source document(s)

AttributesValues
Author
Bibliographic Citation
  • Gendron Nicolas, Chocron Richard, Billoir Paul, Brunier Julien, Camoin-Jau Laurence, Tuffigo Marie, Faille Dorothée, Teissandier Dorian, Gay Juliette, de Raucourt Emmanuelle, Suner Ludovic, Bonnet Corentin, Martin Anne-Céline, Lasne Dominique, Ladhari Chayma, Lebreton Aurélien, Bertoletti Laurent, Ajzenberg Nadine, Gaussem Pascale, Morange Pierre-Emmanuel, Le Cam Duchez Véronique, Viallon Alain, Roy Pierre-Marie, Lillo-Le Louët Agnès, Smadja David M. Dabigatran Level Before Reversal Can Predict Hemostatic Effectiveness of Idarucizumab in a Real-World Setting. Frontiers in Medicine, Frontiers media, 2020, 7, ⟨10.3389/fmed.2020.599626⟩
Title
  • Dabigatran Level Before Reversal Can Predict Hemostatic Effectiveness of Idarucizumab in a Real-World Setting
dc:date
  • 2020
Faceted Search & Find service v1.13.91 as of Aug 16 2018


Alternative Linked Data Documents: ODE     Content Formats:       RDF       ODATA       Microdata      About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data]
OpenLink Virtuoso version 07.20.3229 as of May 14 2019, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (70 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software